|
FY2026
12 months to Feb 28, 2026
|
FY2025
12 months to Feb 28, 2025
|
FY2024
12 months to Feb 29, 2024
|
FY2023
12 months to Feb 28, 2023
|
FY2022
12 months to Feb 28, 2022
|
|
|---|---|---|---|---|---|
| Net Sales | |||||
| Cost of Goods Sold | |||||
| Gross Profit | |||||
| Operating Expenses | |||||
| Research and product development | |||||
| Marketing and selling | |||||
| General and administrative | |||||
| Total Operating Expenses | |||||
| Operating Income | |||||
| Interest and dividend income | |||||
| Net unrealized (loss) gain on marketable securities | |||||
| Income before Income Taxes | |||||
| Income tax expense | |||||
| Net Income | |||||
| Basic Earnings Per Share | |||||
| Diluted Earnings Per Share | |||||
| Weighted Average Shares – Basic | |||||
| Weighted Average Shares – Diluted | |||||
Loading...
